| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 24.41 M USD | 20.46 M USD | 11.22 M USD | 17.52 M USD | 18.32 M USD | 20.28 M USD | 13.88 M USD | 11.39 M USD | 7.58 M USD | 7.91 M USD | 7.05 M USD | 7.25 M USD |
| Depreciation & Amortization | 13.29 M USD | 12.50 M USD | 12.51 M USD | 13.36 M USD | 14.63 M USD | 14.03 M USD | 12.34 M USD | 11.31 M USD | 6.96 M USD | 6.89 M USD | 5.36 M USD | 3.63 M USD |
| Stock-Based Compensation | 4.36 M USD | 4.46 M USD | 4.07 M USD | 3.83 M USD | 6.40 M USD | 2.61 M USD | 997000 USD | 957000 USD | 682000 USD | 462000 USD | 996000 USD | 576000 USD |
| Capital Expenditures | 560000 USD | 1.09 M USD | 1.02 M USD | 982000 USD | 980000 USD | 1.09 M USD | 2.93 M USD | 281000 USD | 104000 USD | 168000 USD | 314000 USD | 6.16 M USD |
| Cash Flow from Investing | -6.79 M USD | -13.24 M USD | -6.73 M USD | -11.48 M USD | -21.32 M USD | -12.16 M USD | -19.64 M USD | -4.98 M USD | 1.05 M USD | -5.34 M USD | -11.91 M USD | -2.84 M USD |
| Cash Flow from Financing | -14.96 M USD | -6.92 M USD | -4.42 M USD | -6.06 M USD | -6.46 M USD | -1.12 M USD | 4.10 M USD | -5.56 M USD | -8.56 M USD | 15000 USD | 5.16 M USD | -5.04 M USD |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock Buybacks | 9.87 M USD | 1.18 M USD | 153000 USD | 5.46 M USD | 560000 USD | 0 USD | 0 USD | 10.39 M USD | — | 75000 USD | 179000 USD | 204000 USD |
| Free Cash Flow | 23.85 M USD | 19.37 M USD | 10.20 M USD | 16.54 M USD | 17.34 M USD | 19.19 M USD | 10.95 M USD | 11.11 M USD | 7.48 M USD | 7.74 M USD | 6.74 M USD | 1.09 M USD |
InfuSystem Holdings Inc. is a leading provider of healthcare services specializing in the supply of durable medical equipment and third-party billing services across the United States and Canada. The company's primary function is to deliver innovative solutions for patients requiring ambulatory infusion pumps for chemotherapy, pain management, and other infusion therapies. Notably, InfuSystem Holdings Inc. supports oncologists and other healthcare stakeholders in managing complex, cost-critical medical treatments outside traditional hospital settings, enhancing patient care and operational efficiencies. It also impacts sectors such as oncology, surgery centers, and home healthcare by offering reliable equipment logistics and comprehensive documentation services. In the financial market, InfuSystem Holdings Inc. represents a critical intersection of healthcare delivery and medical technology, positioning itself as a key player in facilitating advanced medical care with an emphasis on patient comfort and accessibility.